TY - JOUR
T1 - Nanostructured Phthalocyanine Assemblies with Protein-Driven Switchable Photoactivities for Biophotonic Imaging and Therapy
AU - Li, Xingshu
AU - Kim, C. Yoon
AU - Lee, Seunghyun
AU - Lee, Dayoung
AU - Chung, Hyung Min
AU - Kim, Gyoungmi
AU - Heo, Si Hyun
AU - Kim, Chulhong
AU - Hong, Ki Sung
AU - Yoon, Juyoung
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/8/9
Y1 - 2017/8/9
N2 - Switchable phototheranostic nanomaterials are of particular interest for specific biosensing, high-quality imaging, and targeted therapy in the field of precision nanomedicine. Here, we develop a "one-for-all" nanomaterial that self-assembles from flexible and versatile phthalocyanine building blocks. The nanostructured phthalocyanine assemblies (NanoPcTBs) display intrinsically unique photothermal and photoacoustic properties. Fluorescence and reactive oxygen species generation can be triggered depending on a targeted, protein-induced, partial disassembly mechanism, which creates opportunities for low-background fluorescence imaging and activatable photodynamic therapy. In vitro evaluations indicate that NanoPcTB has a high selectivity for biotin receptor-positive cancer cells (e.g., A549) compared to biotin receptor-negative cells (e.g., WI38-VA13) and permits a combined photodynamic and photothermal therapeutic effect. Following systemic administration, the NanoPcTBs accumulate in A549 tumors of xenograft-bearing mice, and laser irradiation clearly induces the inhibition of tumor growth.
AB - Switchable phototheranostic nanomaterials are of particular interest for specific biosensing, high-quality imaging, and targeted therapy in the field of precision nanomedicine. Here, we develop a "one-for-all" nanomaterial that self-assembles from flexible and versatile phthalocyanine building blocks. The nanostructured phthalocyanine assemblies (NanoPcTBs) display intrinsically unique photothermal and photoacoustic properties. Fluorescence and reactive oxygen species generation can be triggered depending on a targeted, protein-induced, partial disassembly mechanism, which creates opportunities for low-background fluorescence imaging and activatable photodynamic therapy. In vitro evaluations indicate that NanoPcTB has a high selectivity for biotin receptor-positive cancer cells (e.g., A549) compared to biotin receptor-negative cells (e.g., WI38-VA13) and permits a combined photodynamic and photothermal therapeutic effect. Following systemic administration, the NanoPcTBs accumulate in A549 tumors of xenograft-bearing mice, and laser irradiation clearly induces the inhibition of tumor growth.
UR - http://www.scopus.com/inward/record.url?scp=85027134694&partnerID=8YFLogxK
U2 - 10.1021/jacs.7b05916
DO - 10.1021/jacs.7b05916
M3 - Article
C2 - 28708389
AN - SCOPUS:85027134694
SN - 0002-7863
VL - 139
SP - 10880
EP - 10886
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 31
ER -